Ad is loading...
ALXO
Price
$1.60
Change
-$0.20 (-11.05%)
Updated
Dec 6, 04:05 PM (EDT)
90 days until earnings call
AMRN
Price
$0.48
Change
-$0.01 (-2.04%)
Updated
Dec 6, 04:04 PM (EDT)
82 days until earnings call
Ad is loading...

ALXO vs AMRN

Header iconALXO vs AMRN Comparison
Open Charts ALXO vs AMRNBanner chart's image
ALX Oncology Holdings
Price$1.60
Change-$0.20 (-11.05%)
Volume$100
CapitalizationN/A
Amarin
Price$0.48
Change-$0.01 (-2.04%)
Volume$100
CapitalizationN/A
ALXO vs AMRN Comparison Chart
Loading...
ALXO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
AMRN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ALXO vs. AMRN commentary
Dec 07, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALXO is a Hold and AMRN is a Hold.

COMPARISON
Comparison
Dec 07, 2024
Stock price -- (ALXO: $1.81 vs. AMRN: $0.49)
Brand notoriety: ALXO: Not notable vs. AMRN: Notable
ALXO represents the Biotechnology, while AMRN is part of the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: ALXO: 219% vs. AMRN: 132%
Market capitalization -- ALXO: $82.28M vs. AMRN: $357.53M
ALXO [@Biotechnology] is valued at $82.28M. AMRN’s [@Pharmaceuticals: Major] market capitalization is $357.53M. The market cap for tickers in the [@Biotechnology] industry ranges from $489.7B to $0. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Biotechnology] industry is $2.71B. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALXO’s FA Score shows that 0 FA rating(s) are green whileAMRN’s FA Score has 0 green FA rating(s).

  • ALXO’s FA Score: 0 green, 5 red.
  • AMRN’s FA Score: 0 green, 5 red.
According to our system of comparison, ALXO is a better buy in the long-term than AMRN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALXO’s TA Score shows that 5 TA indicator(s) are bullish while AMRN’s TA Score has 4 bullish TA indicator(s).

  • ALXO’s TA Score: 5 bullish, 5 bearish.
  • AMRN’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ALXO is a better buy in the short-term than AMRN.

Price Growth

ALXO (@Biotechnology) experienced а +19.87% price change this week, while AMRN (@Pharmaceuticals: Major) price change was -0.18% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.43%. For the same industry, the average monthly price growth was -1.09%, and the average quarterly price growth was +12.58%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.11%. For the same industry, the average monthly price growth was -6.16%, and the average quarterly price growth was -0.01%.

Reported Earning Dates

ALXO is expected to report earnings on Mar 06, 2025.

AMRN is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Biotechnology (+0.43% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Pharmaceuticals: Major (-1.11% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMRN($358M) has a higher market cap than ALXO($82.3M). AMRN YTD gains are higher at: -43.552 vs. ALXO (-87.844). AMRN has higher annual earnings (EBITDA): -50.7M vs. ALXO (-148.58M). AMRN has more cash in the bank: 321M vs. ALXO (149M). AMRN has less debt than ALXO: AMRN (8.74M) vs ALXO (9.84M). AMRN has higher revenues than ALXO: AMRN (307M) vs ALXO (0).
ALXOAMRNALXO / AMRN
Capitalization82.3M358M23%
EBITDA-148.58M-50.7M293%
Gain YTD-87.844-43.552202%
P/E RatioN/A67.11-
Revenue0307M-
Total Cash149M321M46%
Total Debt9.84M8.74M113%
FUNDAMENTALS RATINGS
AMRN: Fundamental Ratings
AMRN
OUTLOOK RATING
1..100
54
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
91
PRICE GROWTH RATING
1..100
85
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALXOAMRN
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 5 days ago
71%
Declines
ODDS (%)
Bearish Trend 19 days ago
90%
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Ad is loading...
ALXO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
AMRN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
JZXN1.470.15
+11.65%
Jiuzi Holdings Inc.
TSLA369.4911.56
+3.23%
Tesla
ELAN12.12-0.13
-1.06%
Elanco Animal Health
KMT27.88-0.37
-1.31%
Kennametal
LEE16.00-0.30
-1.84%
Lee Enterprises

ALXO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALXO has been loosely correlated with MDGL. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ALXO jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALXO
1D Price
Change %
ALXO100%
+16.03%
MDGL - ALXO
56%
Loosely correlated
-1.70%
AXON - ALXO
45%
Loosely correlated
+0.35%
AMRN - ALXO
43%
Loosely correlated
-1.80%
ALNY - ALXO
39%
Loosely correlated
-1.14%
MRNA - ALXO
38%
Loosely correlated
+3.15%
More

AMRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMRN has been loosely correlated with KZR. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if AMRN jumps, then KZR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMRN
1D Price
Change %
AMRN100%
-1.80%
KZR - AMRN
56%
Loosely correlated
-1.42%
CNTB - AMRN
55%
Loosely correlated
-10.71%
HRTX - AMRN
44%
Loosely correlated
+4.88%
MGNX - AMRN
44%
Loosely correlated
-2.87%
ALXO - AMRN
43%
Loosely correlated
+16.03%
More